Company / Operating Cash Flow
MANGOCEUTICALS, INC. Operating Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$5.9M
FY2025
5-year range
-$7.0M / -$1.3M
FY2023-FY2025
Trend
+16.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$1M to -$6M over the past 2 years.
Based on SEC 10-K filings.
-$6M in FY2025.
Declined from -$1M to -$6M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 16.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.9M | +16.4% |
| FY2024 | -$7.0M | -419.7% |
| FY2023 | -$1.3M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026